Literature DB >> 9852321

Glucocorticoid modulation of Ca2+ homeostasis in human B lymphoblasts.

J P Gardner1, L Zhang.   

Abstract

1. We determined the effect of cortisol (200 nM for 48 h) on the intracellular Ca2+ concentration ([Ca2+]i) and parameters of Ca2+i signalling in 19 lymphoblastoid cell lines (LCLs). 2. Using the fluorescent dye fura-2, the basal [Ca2+]i in Ca2+-containing medium was 63.5 +/- 2.4 nM in vehicle (ethanol)-treated LCLs and 55.7 +/- 2. 6 nM (mean +/- s.e.m.) in cortisol-treated LCLs. 3. Ca2+i signalling following platelet-activating factor (PAF, 100 nM) addition was enhanced by cortisol treatment, with LCLs having small PAF responses showing the largest percentage increase after cortisol treatment. Mean peak [Ca2+]i responses to PAF were enhanced 67.0% and 55.7% in Ca2+-free and Ca2+-containing medium, respectively. 4. The endoplasmic reticulum Ca2+-ATPase inhibitor thapsigargin (100 nM) caused a transient increase in [Ca2+]i in Ca2+-free medium in which the peak change was increased in cortisol-treated cells (98.5 +/- 5.8 vs. 79.8 +/- 4.5 nM). Peak changes in the freely exchangeable Ca2+ in response to 5 microM ionomycin were also enhanced in cortisol-treated cells (923.7 +/- 113.9 vs. 652.2 +/- 64.5 nM) and correlated to the PAF-evoked [Ca2+]i response. 5. Cortisol-treated LCLs exposed to thapsigargin to empty intracellular Ca2+ stores (10 min treatment in Ca2+-free medium) and exposed to CaCl2 or MnCl2 had a greater rate of Ca2+ entry (18.6 +/- 1.8 vs. 13.8 +/- 1.5 nM s-1) and higher rate constant for Mn2+ entry (0.0345 +/- 0.0029 vs. 0. 0217 +/- 0.0020) than vehicle-treated cells. Peak [Ca2+]i in cells exposed to CaCl2 was also enhanced (869.4 +/- 114.7 vs. 562.6 +/- 61.7 nM). Parameters of divalent cation influx were highly correlated to the peak [Ca2+]i elicited by thapsigargin or ionomycin. 6. Inclusion of RU 486 (a glucocorticoid antagonist) with cortisol prevented the decrease in basal [Ca2+]i and stimulatory actions of cortisol on all Ca2+i parameters. RU 486 alone had no apparent effects on basal [Ca2+]i or Ca2+i signalling. 7. Based on data obtained over a wide range of responses (in the presence and/or absence of cortisol or RU 486), the results show that cortisol stimulation of glucocorticoid receptors decreases basal [Ca2+]i and enhances PAF-evoked [Ca2+]i signalling, most probably through its effects on intracellular Ca2+ stores. In turn, the extent of Ca2+ entry via store-operated plasma membrane Ca2+ channels is closely linked to the size of the Ca2+ stores.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9852321      PMCID: PMC2269066          DOI: 10.1111/j.1469-7793.1999.385ae.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  64 in total

1.  Calcium oscillations increase the efficiency and specificity of gene expression.

Authors:  R E Dolmetsch; K Xu; R S Lewis
Journal:  Nature       Date:  1998-04-30       Impact factor: 49.962

Review 2.  Capacitative calcium entry revisited.

Authors:  J W Putney
Journal:  Cell Calcium       Date:  1990 Nov-Dec       Impact factor: 6.817

Review 3.  Glucocorticoids and immune function: unknown dimensions and new frontiers.

Authors:  T Wilckens; R De Rijk
Journal:  Immunol Today       Date:  1997-09

4.  Agonists stimulate divalent cation channels in the plasma membrane of human platelets.

Authors:  T J Hallam; T J Rink
Journal:  FEBS Lett       Date:  1985-07-08       Impact factor: 4.124

5.  Effect of glucocorticosteroid treatment on intracellular calcium homeostasis in mouse lymphoma cells.

Authors:  M Lam; G Dubyak; C W Distelhorst
Journal:  Mol Endocrinol       Date:  1993-05

6.  Evidence for a platelet-activating factor receptor on human lymphoblastoid B cells: activation of the phosphatidylinositol cycle and induction of calcium mobilization.

Authors:  P G Schulam; G Putcha; J Franklin-Johnson; W T Shearer
Journal:  Biochem Biophys Res Commun       Date:  1990-01-30       Impact factor: 3.575

7.  Activation of NF-kappa B and immunoglobulin expression in response to platelet-activating factor in a human B cell line.

Authors:  C S Smith; W T Shearer
Journal:  Cell Immunol       Date:  1994-05       Impact factor: 4.868

8.  Cytokine regulation by platelet-activating factor in a human B cell line.

Authors:  C S Smith; L Parker; W T Shearer
Journal:  J Immunol       Date:  1994-11-01       Impact factor: 5.422

Review 9.  Regulation of human B-cell activation and adhesion.

Authors:  E A Clark; P J Lane
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

10.  Role for Ca2+ in expression of cell cycle regulated genes in PAF-stimulated cells.

Authors:  B D Mazer; J Domenico; A Szepesi; J J Lucas; E W Gelfand
Journal:  J Lipid Mediat Cell Signal       Date:  1994-09
View more
  5 in total

1.  Rapid non-genomic inhibition of ATP-induced Cl- secretion by dexamethasone in human bronchial epithelium.

Authors:  V Urbach; D E Walsh; B Mainprice; J Bousquet; B J Harvey
Journal:  J Physiol       Date:  2002-12-15       Impact factor: 5.182

2.  Rapid and non-genomic reduction of intracellular [Ca(2+)] induced by aldosterone in human bronchial epithelium.

Authors:  V Urbach; B J Harvey
Journal:  J Physiol       Date:  2001-11-15       Impact factor: 5.182

Review 3.  Non-genomic Effects of Glucocorticoids: An Updated View.

Authors:  Reynold A Panettieri; Dedmer Schaafsma; Yassine Amrani; Cynthia Koziol-White; Rennolds Ostrom; Omar Tliba
Journal:  Trends Pharmacol Sci       Date:  2018-11-26       Impact factor: 14.819

4.  Dexamethasone stimulates store-operated calcium entry and protein degradation in cultured L6 myotubes through a phospholipase A(2)-dependent mechanism.

Authors:  Kiyoshi Itagaki; Michael Menconi; Bozena Antoniu; Qin Zhang; Patricia Gonnella; David Soybel; Carl Hauser; Per-Olof Hasselgren
Journal:  Am J Physiol Cell Physiol       Date:  2010-01-27       Impact factor: 4.249

5.  Glucocorticoid stimulation increases cardiac contractility by SGK1-dependent SOCE-activation in rat cardiac myocytes.

Authors:  Michael Wester; Anton Heller; Michael Gruber; Lars S Maier; Christian Schach; Stefan Wagner
Journal:  PLoS One       Date:  2019-09-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.